Welcome to Four Square Clobbers Cancer!
Four-Square Clobbers Cancer is a conversational blog that is dedicated to improving the outcomes of children, adolescents, and young adults who are being treated or have been treated for cancer. The goal is to inform, communicate and collaborate with those in the cancer community.
Four-Square is a very popular game played by children, adolescents and even young adults. Following the rules and reacting to the constant changing path of a big orange ball, the object is to stay in the game as long as possible. It’s kind of like the game of life, where the object is to react favorably to the fast, changing things that come your way, stay healthy, live as long as possible and have fun.
Four-Square by definition is also used as an adjective that means firm and resolute, especially in support of someone or something. “We stand four-square in our conviction to improve the therapies and outcomes of children, adolescents, and young adults with cancer.”
Clobber is actually a term used in the game of Four-Square and, coincidently, it means the same thing in the game of life. It’s what everyone wants to do to cancer!
Complete information about Four Square Clobbers Cancer and it’s bloggers can be found by clicking the “About” tab on the menu bar at the top of the page.
Looking for ways to advocate to improve future outcomes of children fighting cancer? THIS is
the most important job we have before us today. Both survivor and bereaved parents worked the House and Senate for over four years to get five very effective, low cost measures passed into law. All five passed in the House and were included in the Senate’s year-end, 2024 package. Only one of the five (Gabriella Miller Kids First Act passed. The rest were taken out and not considered. It’s urgent that we pass the remaining measures as soon as possible. If you have a few minutes, You Can Help!
Nineteen years ago when Conor, my grandson, was diagnosed, at 15 months old, with High Risk Neuroblastoma, a challenging and difficult to cure #ChildhoodCancer. Back then, it had a 30% survival rate. Every night after work, I would get on my home computer trying to find information. What I found was dismal, even terrifying. After a week, I found a story of a 6 year old boy who was diagnosed at 1 yr. old. He gave me the strength of HOPE that I needed to watch Conor take treatments, chemotherapy, radiation, surgery, scans and more. I now have a chance to give HOPE to any parent or grandparent who needs it. You’ll be able to tell Conor is doing great today, so here’s a dose of HOPE. Maybe it will stick with you on your cancer journey with your child. I would love for this to help you as much as the HOPE a little 6 year old boy gave me years ago. Check It Out
“Eleven oncology drugs, maybe 14, are currently in shortage. Four of these — cisplatin, carboplatin, methotrexate and fludarabine — are commonly used to treat cancer in adults and children,” “Patients worry about whether they’ll receive their next treatment, or if switching to another treatment will shorten their lives,” ASCO Chief Medical Officer Julie R. Gralow, MD The FDA is investigating the importation of some critically short drugs from China. Click here for the latest updates








watched everything in our daily life – our cars, entertainment and homes – advance with new science and technology over the decades. However, for DIPG, nothing has changed in the standard treatment. DIPG is exactly the same. Each child receives an outdated 6-week course of radiation and a hug for good luck with a 6-9 month life expectancy. From what the doctor told him when diagnosed, Jace had 9 months to live. He went home and calculated it; he was “scheduled” to die on the day before he was to celebrate his 21st birthday. He was not about to let that happen! He and his mother began praying and got busy looking for the best treatments and if not one to cure it, then at least something that would prolong his life. They eventually found a revolutionary trial at Stanford in California.
several infusions over periods of time. Because of his age, and his acute knowledge of the disease, unlike the very young children that typically have this tumor, Jace was able to communicate exactly what his body was going through each time he was infused. Jace knew what his situation was and was acutely aware that the outcome for him would not necessarily work with these early trials. He gladly used his body and treatment experiences to gain as much detailed information as possible. He knew his medical data coupled with his ability to provide pinpoint information was invaluable to the medical and research teams in helping them refine the process for others who would follow him. Jace and many others familiar with DIPG believe delivering CAR T-cells directly to the tumor is the most promising method to find a possible cure for this terrible disease that is killing our children.
To expand the DIPG Car T Cell trial, Stanford needs a dedicated research Fellow, a Cell Pharmacist, and a research Nurse Practitioner. The Fellow and Cell Pharmacist have been funded and began work this month. The last step now is getting the Nurse Practitioner (NP) funded for two years. The Nurse Practitioner is responsible for gathering the correlative data from patients including blood draws, recording symptoms, managing medication for pain and inflammation. Each patient is different and all information is so important to gather. We need to be able to have more kids enrolled in trials as soon as possible to help the children live longer, and perhaps find a cure. We also need to learn from these children. 


